| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Medicine and
Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461; and
Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
NZB/W F1 mice with established nephritis were treated with a single dose of cyclophosphamide with or without a 2-wk course of murine CTLA4Ig, either alone or in combination with anti-CD154. Sixty to 80% of treated mice entered remission, and remission could be reinduced following relapse. A decrease in the frequency of anti-DNA-producing B cells and activated T cells was observed in treated mice, but this effect lasted only 3–6 wk, while remissions were sustained for up to 20 wk. Light microscopy of the kidneys of mice in remission revealed less glomerular inflammation, less tubular damage, and less infiltration of inflammatory cells. By immunofluorescence, however, IgG and C3 staining of glomeruli was no different in treated mice vs controls. Since chemokines and their receptors play an important role in inflammatory cell infiltration of affected organs in autoimmune diseases, we examined chemokine expression in the kidneys. Decreases in the expression of inflammatory cytokines and chemokines were evident in mice in the early stages of remission, but these differences were no longer present in late remission. Increased expression of CXCL13 was detected in the inflammatory infiltrates of the control NZB/NZW mice. Strikingly, we could not detect any CXCL13 in the kidneys of the treated group even in late remission. These findings suggest that costimulatory blockade together with cyclophosphamide influence the activation state of renal CD11c-positive cells and therefore lead to less B and T cell infiltration and nephritis.
This article has been cited by other articles:
|
|
 |
|
  L. Schiffer, P. Kumpers, Ana. M. Davalos-Misslitz, M. Haubitz, H. Haller, H.-J. Anders, T. Witte, and M. Schiffer B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE) Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3708 - 3712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Odegard, L. D. DiPlacido, L. Greenwald, M. Kashgarian, D. H. Kono, C. Dong, R. A. Flavell, and J. Craft ICOS Controls Effector Function but Not Trafficking Receptor Expression of Kidney-Infiltrating Effector T Cells in Murine Lupus J. Immunol., April 1, 2009; 182(7): 4076 - 4084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Karim, C. N. Pisoni, and M. A. Khamashta Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not! Rheumatology, April 1, 2009; 48(4): 332 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lui, S Yung, R Tsang, F Zhang, K. Chan, S Tam, and T. Chan Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice Lupus, April 1, 2008; 17(4): 305 - 313. [Abstract] [PDF]
|
|
|
|
|
|
L. Schiffer, R. Bethunaickan, M. Ramanujam, W. Huang, M. Schiffer, H. Tao, M. M. Madaio, E. P. Bottinger, and A. Davidson Activated Renal Macrophages Are Markers of Disease Onset and Disease Remission in Lupus Nephritis J. Immunol., February 1, 2008; 180(3): 1938 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bagavant, U. S. Deshmukh, H. Wang, T. Ly, and S. M. Fu Role for Nephritogenic T Cells in Lupus Glomerulonephritis: Progression to Renal Failure Is Accompanied by T Cell Activation and Expansion in Regional Lymph Nodes J. Immunol., December 1, 2006; 177(11): 8258 - 8265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-K. Kang, M. A. Michaels, B. R. Berner, and S. K. Datta Very Low-Dose Tolerance with Nucleosomal Peptides Controls Lupus and Induces Potent Regulatory T Cell Subsets J. Immunol., March 15, 2005; 174(6): 3247 - 3255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Davidson, B Diamond, D Wofsy, and D Daikh Block and tackle: CTLA4Ig takes on lupus Lupus, March 1, 2005; 14(3): 197 - 203. [Abstract] [PDF]
|
|
|
|
|
|
C G Parks, L L Hudson, G S Cooper, M A Dooley, E L Treadwell, E W St Clair, G S Gilkeson, and J P Pandey CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States Lupus, October 1, 2004; 13(10): 784 - 791. [Abstract] [PDF]
|
|
|
|
|
|
M. Ramanujam, X. Wang, W. Huang, L. Schiffer, C. Grimaldi, A. Akkerman, B. Diamond, M. P. Madaio, and A. Davidson Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus J. Immunol., September 1, 2004; 173(5): 3524 - 3534. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
